Growth hormone increases final height in patients with juvenile idiopathic arthritis: Data from a randomized controlled study

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 8, 2007, Pages 3013-3018

  Bechtold, Susanne ^a   Ripperger, Peter ^b   Dalla Pozza, Robert ^a   Bonfig, Walter ^a   Häfner, Renate ^b   Michels, Hartmut ^b   Schwarz, Hans Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Children's Rheumatology Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ETANERCEPT; GLUCOCORTICOID; HUMAN GROWTH HORMONE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; INFANT; JUVENILE RHEUMATOID ARTHRITIS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 34547743976     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0544     Document Type: Article

References (28)

1. Robinson IC, Gabrielsson B, Klaus G, Mauras N, Holmberg C, Mehls O 1995 Glucocorticoids and growth problems. Workshop report. Acta Paediatr Suppl 411:81-86
2. Falcini F, Taccetti G, Trapani S, Tafi L, Volpi M 1991 Growth retardation in juvenile chronic arthritis patients treated with steroids. Clin Exp Rheumatol 9:37-40
3. Kontaniemi A 1997 Growth retardation and bone loss as determinants of axial osteopenia in juvenile chronic arthritis. Scand J Rheumatol 26:14-18
4. Zak M, Hassager C, Lovell DJ, Nielsen S, Henderson CJ, Pedersen FK 1999 Assessment of bone mineral density in adults with a history of juvenile chronic arthritis. Arthritis Rheum 42:790-798
5. Simon D, Fernando C, Czernichow P, Prieur AM 2002 Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol 29:1296-1300
6. Underwood LE 1999 Growth retardation in chronic disease: possible mechanisms. Acta Paediatr Suppl 428:93-96
7. Davies UM, Jones J, Reeve J, Camacho-Hubner C, Charlett A, Ansell BM, Preece MA, Woo PMM 1997 Juvenile rheumatoid arthritis: effects of disease activity and recombinant human growth hormone and insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arthritis Rheum 40:332-340
8. Touati G, Prieur AM, Ruiz JC, Noel M, Czernichow P 1998 Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition. J Clin Endocrinol Metab 83:403-409
9. Bechtold S, Ripperger P, Mühlbayer D, Truckenbrodt H, Häfner R, Butenandt O, Schwarz HP 2001 Growth hormone therapy in juvenile rheumatoid arthritis: results of a two-year controlled study on growth and bone. J Clin Endocrinol Metab 86:5737-5744
10. Bechtold S, Ripperger P, Häfner R, Said E, Schwarz HP 2003 Growth hormone therapy in juvenile idiopathic arthritis: 4 years data of a controlled study. J Pediatrics 143:512-519
11. Svantesson H 1991 Treatment of growth failure with human growth hormone in patients with juvenile chronic arthritis. A pilot study. Clin Exp Rheumatol 9(Suppl 6):47-50
12. Allen DB, Julius JR, Breen TJ, Attie KM 1998 Treatment of glucocorticoid induced growth suppression with growth hormone. J Clin Endocrinol Metab 83:2824-2829
13. Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P 2003 Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy. J Rheumatol 30:2492-2499
14. Petty, RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM 1998 Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol 25:1991-1994
15. Prader A, Largo RH, Molinari L, Issler C 1989 Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1-125
16. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 45:755-762
17. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Palo Alto, CA: Stanford University Press
18. Tanner JM 1962 Growth at adolescence. 2nd ed. Oxford, UK: Blackwell Scientific
19. Gasser T 1991 Analysing curves using kernel estimators. Pediatr Nephrol 5:447-450
20. Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB 2006 Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab 91:2047-2054
21. Haffner D, Schaefer F, Nissel R, Wuhl E, Tönshoff B, Mehls O 2000 Effect of growth hormone treatment on adult height of children with chronic renal failure. German study group for growth hormone treatment in chronic renal failure. N Engl J Med 343:923-930
22. Van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL 2003 Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88:1119-1125
23. Donaldson MDC 1997 Growth hormone therapy in Turner syndrome: current uncertainties and future strategies. Horm Res 48(Suppl 5):3-44
24. August GP, Julius JR, Blethen SL 1998 Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: National Cooperative Study experience. Pediatrics 102:512-516
25. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, Fattori E 1997 Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor one. J Clin Invest 99:643-650
26. De Benedetti F, Meazza C, Olivieri M, Pignatti P, Vivarelli M, Alonzi T, Fattori E, Garrone S, Barreca A, Martini A 2001 Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 142:4818-4826
27. Delharty PJD 1998 Interleukin-1β suppress growth hormone-induced acid-labile subunit mRNA levels and secretion in primary hepatocytes. Biochem Biophys Res Commun 243:269-272
28. Aitman TJ, Palmer RG, Loftus J, Ansell BM, Royston JP, Teale JD, Clayton RN 1989 Serum IGF-I levels and growth failure in juvenile chronic arthritis. Clin Exp Rheumatol 7:557-561